Equivalent Products definition

Equivalent Products means copolymers prepared by a process other than anionic polymerisation, but otherwise meeting all specifications for any of the Products coming within the definition of Products.
View Source
Equivalent Products means any products which have the same or substantially the same external appearance, base function and internal components of the Products, or are functionally equivalent thereto, but which do not bear or otherwise display any of the AB Trademarks.
View Source
Equivalent Products means veterinary diagnostic products in ICT Format that (i) are for the same analytes as Products, and (ii) do not contain Synbiotics Biologicals.
View Source

Examples of Equivalent Products in a sentence

  • In the event Purchaser elects to obtain such alternative products, Purchaser shall still be obligated to pay to Seller the Purchase Price amounts as calculated under Exhibit B; provided, however, that there shall be subtracted from such amounts Purchaser’s actual direct cost of such alternative Equivalent Products.

  • Purchaser shall be permitted to obtain such Equivalent Products from alternative sources solely for that period of time as Seller is unable to deliver Product to Purchaser under this Agreement.

  • Equivalent Products – Products other than Core Products which are substantially similar to the product descriptions of Core Products.

  • As of the Execution Date, Andrx hereby grants to GSK a non-exclusive license (without the right to sublicense except that sublicenses are permitted as to GSK’s Affiliates, the GSK Suppliers and, if applicable, GSK’s Third Party distributors of Generic Equivalent Products and as permitted pursuant to Section 3(f)) under the Patent to make, have made, use, sell, have sold, offer for sale and import any Generic Equivalent Products in the United States.

  • Equivalent Products – Products other than Core Products which are substantially similar to the applicable Core Products.

  • As consideration for the license rights under the Patent granted to GSK by Andrx in Paragraph 3(b), GSK (or its Affiliate) shall remit to Andrx (or its Affiliate) a royalty equal to {***}† of GSK’s Net Sales of Generic Equivalent Products in the United States (the “Generic Equivalent Product Royalty”).

  • For the avoidance of doubt, sales of Requested 1-D Products (A) by ▇▇▇▇▇▇ to third parties on and after the Section 8.3 Sale Date will be deemed sales of Equivalent Products and (B) by ▇▇▇▇▇▇ to AB shall be deemed sales of Products and, in each case, such sales will be taken into account in the computations with respect to the Adjusted Contract Year Purchase Minimums as set forth in Schedule 2.

  • GSK shall have the right, in GSK’s sole discretion and without Andrx’s consent, to assign to Biovail Laboratories SRL (“Biovail”) (or an Affiliate of Biovail) (the “Biovail Assignee”), whether on a permanent or on a temporary basis, all or a part of the rights granted to GSK pursuant to Section 3(b) as to Generic Equivalent Products and/or the rights granted to GSK pursuant to Section 3(c) as to Biovail Third Party Licensee Bupropion Products (as applicable, the “Assigned License Rights”).

  • Buyer will issue POs from time to time to Supplier for all of Buyer’s requirements of Products and any Functionally Equivalent Products.

  • The transfer prices for Products sold by ▇▇▇▇▇▇ to AB from the Effective Date until December 31, 2004 shall be the transfer prices set forth in Schedule 1 attached hereto; provided that such transfer prices shall be not less favorable to AB than any transfer prices for Equivalent Products offered by ▇▇▇▇▇▇ to any other customer or distributor under substantially similar circumstances (e.g., substantially similar purchase commitments and volumes).

Related to Equivalent Products

  • Therapeutically equivalent drug products means drug products that contain the same active ingredients and are identical in strength or concentration, dosage form, and route of administration and that are classified as being therapeutically equivalent by the U.S. Food and Drug Administration pursuant to the definition of "therapeutically equivalent drug products" set forth in the most recent edition of the Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the "Orange Book."

  • Combination Products means COBI Combination Products, EVG Combination Products, TDF Combination Products, TAF Combination Products and Quad Product.

  • Combination Product means a product (a) containing a Licensed Product together with one or more other active ingredients, or (b) with one or more products, devices, pieces of equipment or components, but sold for an integrated price (e.g., with the purchase of one product the customer gets a coupon for the other) or for a single price.

  • Therapeutic equivalent means that a Covered Drug can be expected to produce essentially the same therapeutic outcome and toxicity.

  • Generic Equivalent or "generically equivalent" means a drug that has an identical amount of the same active chemical ingredients in the same dosage form, that meets applicable standards of strength, quality and purity according to the United States pharmacopeia or other nationally recognized compendium and that, if administered in the same amounts, will provide comparable therapeutic effects. Generic equivalent or generically equivalent does not include a drug that is listed by the federal food and drug administration as having unresolved bioequivalence concerns according to the administration's most recent publication of approved drug products with therapeutic equivalence evaluations.